Allogeneic transplant for FLT3-ITD+ AML: room for improvement.

about

Allogeneic transplant for FLT3-ITD+ AML: room for improvement.

Item

http://www.wikidata.org/entity/Q54208508

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Allogeneic transplant for FLT3-ITD+ AML: room for improvement.

@en

Allogeneic transplant for FLT3-ITD+ AML: room for improvement.

@nl

type

Item

label

Allogeneic transplant for FLT3-ITD+ AML: room for improvement.

@en

Allogeneic transplant for FLT3-ITD+ AML: room for improvement.

@nl

prefLabel

Allogeneic transplant for FLT3-ITD+ AML: room for improvement.

@en

Allogeneic transplant for FLT3-ITD+ AML: room for improvement.

@nl

P1476

Allogeneic transplant for FLT3-ITD+ AML: room for improvement.

@en

P2093

A E Perl

http://www.w3.org/2001/XMLSchema#string

S M Luger

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.

Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis.

No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): an analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRC AML10 and 12 trials.

Phase I trial of maintenance sorafenib after allogeneic hematopoietic stem cell transplantation for fms-like tyrosine kinase 3 internal tandem duplication acute myeloid leukemia.

Improved FLT3 internal tandem duplication PCR assay predicts outcome after allogeneic transplant for acute myeloid leukemia.

Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantation

Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association.

Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantation.

Clinical implications of FLT3 mutations in pediatric AML.

P2888

bmt.2016.37

P304

508-510

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BMT.2016.37

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26974268

http://www.w3.org/2001/XMLSchema#string